BSE - Delayed Quote INR
Global Health Limited (MEDANTA.BO)
1,242.45
-4.65
(-0.37%)
At close: 3:29:39 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
35,355,300
32,409,420
26,828,040
21,672,979
14,293,240
Cost of Revenue
8,597,910
7,593,600
6,252,850
5,429,269
3,485,580
Gross Profit
26,757,390
24,815,820
20,575,190
16,243,710
10,807,660
Operating Expense
19,960,150
18,141,340
15,584,560
12,995,110
9,880,690
Operating Income
6,797,240
6,674,480
4,990,630
3,248,600
926,970
Net Non Operating Interest Income Expense
-186,480
-241,030
-507,930
-794,860
-548,830
Pretax Income
6,569,060
6,270,990
4,492,900
2,805,571
324,640
Tax Provision
1,496,190
1,490,390
1,232,110
843,592
36,590
Net Income Common Stockholders
5,074,180
4,781,940
3,260,790
1,961,979
288,050
Diluted NI Available to Com Stockholders
5,074,180
4,781,940
3,260,790
1,961,979
288,050
Basic EPS
18.87
17.80
12.58
7.75
1.15
Diluted EPS
18.87
17.80
12.57
7.73
1.14
Basic Average Shares
268,874.73
268,607.38
259,208.85
253,236.43
251,408.99
Diluted Average Shares
268,874.73
268,607.38
259,460.83
253,650.50
252,056.39
Rent Expense Supplemental
--
621,050
633,670
537,560
364,940
Total Expenses
28,558,060
25,734,940
21,837,410
18,424,379
13,366,270
Net Income from Continuing & Discontinued Operation
5,074,180
4,781,940
3,260,790
1,961,979
288,050
Normalized Income
5,269,880.25
4,999,152.33
3,320,999.47
1,985,306.76
388,003.28
Interest Income
--
596,780
355,360
167,220
177,580
Interest Expense
670,840
725,390
774,640
794,860
671,010
Net Interest Income
-186,480
-241,030
-507,930
-794,860
-548,830
EBIT
7,239,900
6,996,380
5,267,540
3,600,431
995,650
EBITDA
9,139,370
8,723,660
6,766,690
4,897,560
2,227,790
Reconciled Cost of Revenue
8,597,910
7,593,600
6,252,850
5,429,269
3,485,580
Reconciled Depreciation
1,899,470
1,727,280
1,499,150
1,297,129
1,232,140
Net Income from Continuing Operation Net Minority Interest
5,074,180
4,781,940
3,260,790
1,961,979
288,050
Total Unusual Items Excluding Goodwill
-253,420
-284,930
-82,960
-33,358
-112,650
Total Unusual Items
-253,420
-284,930
-82,960
-33,358
-112,650
Normalized EBITDA
9,392,790
9,008,590
6,849,650
4,930,918
2,340,440
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-57,719.75
-67,717.67
-22,750.53
-10,030.24
-12,696.72
3/31/2021 - 11/16/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade